New avenues in childhood vasculitis.
Exploring childhood vasculitis: recent advances in diagnosis, treatment, and future directions. ๐๐ฉบ
October 8, 2025
Follow us
latest articles
Discover the newest research about AI innovations in ๐งฌ Rare Diseases.
New Wearable Device Aims to Monitor Muscle Health in Older Adults
New wearable device monitors muscle health in older adults. ๐ฆต๐ Aims to detect sarcopenia for timely intervention.
September 29, 2025
Lung lobe segmentation: performance of open-source MOOSE, TotalSegmentator, and LungMask models compared to a local in-house model.
Lung lobe segmentation tools evaluated: TotalSegmentator excels, while data diversity enhances model accuracy. ๐๐ซ
September 5, 2025
Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005-2025).
๐ Retinoblastoma biomarkers research shows steady growth, with China leading publications. Key hotspots include liquid biopsy and AI integration. ๐ฌ
August 16, 2025
Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy.
Bimodal imaging probes enhance disease diagnosis and therapy, combining MRI and fluorescence for improved precision. ๐งฌ๐ฌ
August 4, 2025
Open-Source AI Tools Enhance Medical Scan Reporting for Doctors
Open-source AI tools can assist doctors in reading medical scans effectively and affordably, ensuring patient privacy. ๐ฅ๐ค
August 1, 2025
Collaboration Between UHL, UHN, and Microsoft to Enhance AI in Healthcare
UHL, UHN, and Microsoft partner to advance AI in healthcare, aiming to improve patient care and streamline services. ๐ค๐ป
July 31, 2025
The Artificial Intelligence-Assisted Diagnosis of Skeletal Dysplasias in Pediatric Patients: A Comparative Benchmark Study of Large Language Models and a Clinical Expert Group.
AI models show 62.2% accuracy in diagnosing skeletal dysplasias, compared to 82.2% by clinical experts. ๐ค๐
July 29, 2025
AI Enhances Clinical Trials for Alzheimer’s Drug Development
AI improves Alzheimer’s drug trials by accurately identifying patient groups, potentially speeding up effective treatment development. ๐ง ๐
July 28, 2025
New tools for diagnosis of primary immunodeficiencies: from awareness to artificial intelligence.
New diagnostic tools for primary immunodeficiencies: AI and expert-driven strategies show promise in early detection. ๐งฌ๐
July 25, 2025